Clinical Trial Update: MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) [NA]

View source ↗

Summary

Completed clinical trial of MedJ-01 Ridaforolimus-eluting coronary stent system (JNIR) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• MedJ-01 Ridaforolimus-eluting coronary stent system (JNIR) (ridaforolimus-eluting coronary stent system)

Snippet

Sponsor: Medinol Ltd. | Conditions: de Novo or Restenosis Lesions | NA | Status: COMPLETED | Results posted: 2020-09-24